Genetic ‘Trojan horse’ selectively kills cancer cells linked to Kaposi’s sarcoma

In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with minimal side effects.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup